- Symptomatic treatment of recurrent vertigo with/without cochlear signs
- Symptomatic treatment of vestibular vertigo
- Meniere Syndrome characterized by: vertigo, hearing loss or tinnitus
PO 8-16mg TDS
Tablet: 8mg
To be taken with food
Partial H1receptor agonist and H3 receptor antagonist. Non-sedative.
- Nausea
- Dyspepsia
- Headaches
- Hypersensitivity reactions
- Hypersensitivity to components
- Pheochromocytoma
- MAOIs
Drug Status
| Availability | Prescription or OTC by Pharmacist |
| Pregnancy | Unknown; Weigh risk vs benefit |
| Breastfeeding | Unknown; Weigh risk vs benefit |
| Schedule | Not controlled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| Besdiz | 16mg | Tablet | 30’s | Medisel Kenya | Medisel Kenya |
| Besdiz | 16mg | Tablet | 30’s | Medisel Kenya | Medisel Kenya |
| Be-Stedy | 16mg | Tablet | 100’s | Aurobindo Pharma | Simba Pharma |
| Be-Stedy | 24mg | Tablet | 100’s | Aurobindo Pharma | Simba Pharma |
| Betaserc | 8mg | Tablet | 100’s | Abbott Labs | Harley’s Ltd |
| Betavert | 16mg | Tablet | 100’s | Sun Pharma | Sun Pharma |
| Betavert | 24mg | Tablet | 50’s | Sun Pharma | Sun Pharma |
| Vertease | 16mg | Tablet | 30s | Pharmevo | Harley’s Ltd |